Related Practice Life Sciences & Pharma Notwithstanding COVID-19, existing infectious diseases wreak significant health, social and economic havoc across the world each year. 01262021170148
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Case Study Biotech and Pharmaceuticals Late Lifecycle Strategy Assessment for a Biologic April 30, 2024
Executive Insights Diagnostics, Tools and Personalized Medicine Commercial Excellence in Life Sciences Tools and Services Companies April 8, 2024
Special Report Biotech and Pharmaceuticals Scope 3 Emissions: A Strategic Imperative for Pharma Companies March 19, 2024
Executive Insights Healthcare Services Navigating Asia’s Regulatory Mosaic: Achieving Excellence in Generative AI for Healthcare January 26, 2024
Article Life Sciences & Pharma Hospital Priorities in China in 2023: Strategic Implications for Pharma Companies December 7, 2023